Cargando…
A comparative, observational study evaluating dosing characteristics and ovarian response using the recombinant human follicle-stimulating hormone pen injector with small-dose dial in assisted reproductive technologies treatment in Asia: IMPROVE study
BACKGROUND: Ovarian stimulation during medically assisted reproduction treatment should be individualized to optimize outcomes and reduce complications. This study assessed whether use of the recombinant human follicle-stimulating hormone (r-hFSH) pen injector allowing small 12.5 IU dose increments...
Autores principales: | Choi, Bum Chae, Zhou, Canquan, Ye, Hong, Sun, Yun, Zhong, Ying, Gong, Fei, Sini, Ivan, Abramova, Nadezda, Longobardi, Salvatore, Hickey, Miranda, D’Hooghe, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762890/ https://www.ncbi.nlm.nih.gov/pubmed/35039049 http://dx.doi.org/10.1186/s12958-021-00882-2 |
Ejemplares similares
-
Formative usability evaluation of a fixed-dose pen-injector platform device
por: Lange, Jakob, et al.
Publicado: (2018) -
Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007–2017)
por: Fatemi, Human, et al.
Publicado: (2021) -
Comparison of the injection‐site experience of semaglutide in a single‐dose and a multidose pen‐injector
por: Snitker, Søren, et al.
Publicado: (2022) -
Recombinant Human Follicle-Stimulating Hormone Alfa Dose Adjustment in US Clinical Practice: An Observational, Retrospective Analysis of a Real-World Electronic Medical Records Database
por: Mahony, Mary C., et al.
Publicado: (2021) -
Fine-tuning the dose of recombinant human follicle-stimulating hormone alfa to individualize treatment in ovulation induction and ovarian stimulation cycles: a real-world database analysis
por: Martini, Anne E., et al.
Publicado: (2023)